Literature DB >> 31722438

The Second Gaddum Lecture: its origins and outcomes.

Y S Bakhle1.   

Abstract

Fifty years ago, the BJP published the Second Gaddum Lecture, given by John Vane to the British Pharmacological Society. This article assesses the origins of the experiments described in the Lecture, linking them directly to Gaddum's use of bioassay, a defining feature of pharmacology. The outcomes of those experiments are also assessed, tracking those results that have survived the past five decades. Two of the major advances in cardiovascular medicine, the ACE inhibitors, as anti-hypertensives, and low-dose aspirin, to prevent thrombosis were initiated by the work in this Lecture. Physiologically significant outcomes include a new non-respiratory function of the lung, based on the metabolism of endogenous vasoactive substrates in the pulmonary circulation and the recognition of the endothelium as a highly interactive component of blood vessels. The present state of the art in pharmacology, physiology and medicine owes much to the work described in the Second Gaddum Lecture.
© 2019 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31722438      PMCID: PMC7042101          DOI: 10.1111/bph.14928

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  68 in total

1.  THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1964-10

2.  Sir John Robert Vane: 29 March 1927 - 19 November 2004.

Authors:  Salvador Moncada
Journal:  Biogr Mem Fellows R Soc       Date:  2006

3.  Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.

Authors:  Gholamreza Roshandel; Masoud Khoshnia; Hossein Poustchi; Karla Hemming; Farin Kamangar; Abdolsamad Gharavi; Mohammad Reza Ostovaneh; Alireza Nateghi; Masoud Majed; Behrooz Navabakhsh; Shahin Merat; Akram Pourshams; Mahdi Nalini; Fatemeh Malekzadeh; Masoumeh Sadeghi; Noushin Mohammadifard; Nizal Sarrafzadegan; Mohammad Naemi-Tabiei; Abdolreza Fazel; Paul Brennan; Arash Etemadi; Paolo Boffetta; Neil Thomas; Tom Marshall; Kar Keung Cheng; Reza Malekzadeh
Journal:  Lancet       Date:  2019-08-24       Impact factor: 79.321

4.  Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme.

Authors:  S H Ferreira; L H Greene; V A Alabaster; Y S Bakhle; J R Vane
Journal:  Nature       Date:  1970-01-24       Impact factor: 49.962

5.  Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

Authors:  P J Piper; J R Vane
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

6.  Fate of angiotensin I in the circulation.

Authors:  K K Ng; J R Vane
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

Review 7.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 8.  Genetic regulation of dimethylarginines and endothelial dysfunction in rheumatoid arthritis.

Authors:  Theodoros Dimitroulas; George D Kitas
Journal:  Amino Acids       Date:  2019-05-06       Impact factor: 3.520

Review 9.  The Croonian Lecture, 1993. The endothelium: maestro of the blood circulation.

Authors:  J R Vane
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1994-01-29       Impact factor: 6.237

Review 10.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

View more
  1 in total

Review 1.  The Second Gaddum Lecture: its origins and outcomes.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  2020-02-05       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.